Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Gross Margin (2017 - 2026)

Inspire Medical Systems' Gross Margin history spans 10 years, with the latest figure at 86.47% for Q1 2026.

  • On a quarterly basis, Gross Margin rose 173.0% to 86.47% in Q1 2026 year-over-year; TTM through Mar 2026 was 85.78%, a 112.0% increase, with the full-year FY2025 number at 85.39%, up 71.0% from a year prior.
  • Gross Margin hit 86.47% in Q1 2026 for Inspire Medical Systems, roughly flat from 86.59% in the prior quarter.
  • Over the last five years, Gross Margin for INSP hit a ceiling of 86.59% in Q4 2025 and a floor of 81.88% in Q3 2022.
  • Historically, Gross Margin has averaged 84.72% across 5 years, with a median of 84.75% in 2025.
  • Biggest five-year swings in Gross Margin: plummeted -414bps in 2022 and later skyrocketed 222bps in 2023.
  • Tracing INSP's Gross Margin over 5 years: stood at 83.94% in 2022, then rose by 2bps to 85.43% in 2023, then decreased by -1bps to 84.99% in 2024, then grew by 2bps to 86.59% in 2025, then dropped by 0bps to 86.47% in 2026.
  • Business Quant data shows Gross Margin for INSP at 86.47% in Q1 2026, 86.59% in Q4 2025, and 85.85% in Q3 2025.